Overview

The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders

Status:
Not yet recruiting
Trial end date:
2023-09-30
Target enrollment:
0
Participant gender:
Female
Summary
To evaulate the role of Myo-inositol, somatropin, DHEA on ICSI outcome in poor ovarian responder
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Beni-Suef University
Treatments:
Dehydroepiandrosterone
Inositol
Criteria
Inclusion Criteria:

- 1-Infertile women who have one of the criteria of poor ovarian response as follows ;

- Antral follicle count less than 7

- Anti-Mullerian hormone level Less than 1.2 ng/ml 2- females with body mass index (BMI)
from 19-25

Exclusion Criteria:

- 1- Any endocrine or metabolic disorder such as polycystic ovary syndrome,
hyperprolactinemia, diabetes and thyroid dysfunction.

2- Any pelvic pathology such as hydrosalpinx, uterine anomaly. 3- any male factor
infertility such as Oligo-Astheno-Teratozoospermia (OAT) or Azoospermia.